Tag: Vaccine Policy


  • Political Science and Public Health Faculty Partner on Groundbreaking Vaccine Study

    Political Science and Public Health Faculty Partner on Groundbreaking Vaccine Study

    A Cross-Disciplinary Effort to Understand Vaccine Uptake A collaborative research initiative between the Political Science and Public Health faculties seeks to unpack how vaccine policies influence vaccination rates, public trust, and health equity. The project will analyze longitudinal survey data from the pandemic period, focusing on the interplay between policy environments and individual decisions about…

  • Political Science and Public Health Faculty Partner on Vaccine Study

    Political Science and Public Health Faculty Partner on Vaccine Study

    A Cross-Disciplinary Look at Vaccine Policy A new, joint effort between political science and public health faculties is launching a longitudinal study on how state vaccine policies shape who gets vaccinated and why. Building on a rich history of COVID-19 research, the project aims to reveal how political beliefs, access to care, and demographic factors…

  • Vaccine Policy Study by Political Science and Public Health

    Vaccine Policy Study by Political Science and Public Health

    Collaborative Effort Between Political Science and Public Health A major interdisciplinary study is underway to examine how state vaccine policies influence vaccination rates, public attitudes, and health outcomes. The research team brings together expertise from political science and public health to explore a question at the intersection of policy, behavior, and health equity: Do mandates…

  • Fluad Adjuvanted Flu Vaccine for 65+ Seniors: Protection

    Fluad Adjuvanted Flu Vaccine for 65+ Seniors: Protection

    What Fluad Is and Why It Matters for 65+ Fluad (Seqirus) is an improved trivalent influenza vaccine that includes an adjuvant. It is designed to bolster and prolong the immune response, a feature particularly important for people aged 65 and older, who face higher risks from influenza due to immunosenescence. The vaccine contains two A…